These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 26666288)
1. Underuse of anticoagulation in patients with atrial fibrillation. Vallakati A; Lewis WR Postgrad Med; 2016; 128(2):191-200. PubMed ID: 26666288 [TBL] [Abstract][Full Text] [Related]
2. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study. Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M; Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108 [TBL] [Abstract][Full Text] [Related]
3. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
4. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation. Overvad TF; Larsen TB; Albertsen IE; Rasmussen LH; Lip GY Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1619-29. PubMed ID: 24215192 [TBL] [Abstract][Full Text] [Related]
5. Use of Warfarin at Discharge Among Acute Ischemic Stroke Patients With Nonvalvular Atrial Fibrillation in China. Yang X; Li Z; Zhao X; Wang C; Liu L; Wang C; Pan Y; Li H; Wang D; Hart RG; Wang Y; Wang Y; Stroke; 2016 Feb; 47(2):464-70. PubMed ID: 26696643 [TBL] [Abstract][Full Text] [Related]
6. Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation. Rivera-Caravaca JM; Esteve-Pastor MA; Roldán V; Marín F; Lip GYH Expert Opin Drug Saf; 2017 Sep; 16(9):1051-1062. PubMed ID: 28678553 [TBL] [Abstract][Full Text] [Related]
7. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422 [TBL] [Abstract][Full Text] [Related]
8. Oral anticoagulant therapy for stroke prevention in patients with atrial fibrillation undergoing ablation: results from the First European Snapshot Survey on Procedural Routines for Atrial Fibrillation Ablation (ESS-PRAFA). Potpara TS; Larsen TB; Deharo JC; Rossvoll O; Dagres N; Todd D; Pison L; Proclemer A; Purefellner H; Blomström-Lundqvist C; Europace; 2015 Jun; 17(6):986-93. PubMed ID: 26023177 [TBL] [Abstract][Full Text] [Related]
9. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation. Garcia DA Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997 [TBL] [Abstract][Full Text] [Related]
10. Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage. Chao TF; Liu CJ; Liao JN; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chen TJ; Lip GY; Chen SA Circulation; 2016 Apr; 133(16):1540-7. PubMed ID: 26969761 [TBL] [Abstract][Full Text] [Related]
11. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744 [TBL] [Abstract][Full Text] [Related]
12. Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey. Lip GY; Bongiorni MG; Dobreanu D; Lewalter T; Hastrup Svendsen J; Blomström-Lundqvist C; Europace; 2013 Oct; 15(10):1526-32. PubMed ID: 24072770 [TBL] [Abstract][Full Text] [Related]
13. Stroke Prevention in Atrial Fibrillation: The Role of Oral Anticoagulation. Mtwesi V; Amit G Med Clin North Am; 2019 Sep; 103(5):847-862. PubMed ID: 31378330 [TBL] [Abstract][Full Text] [Related]
14. [Reasons for underuse of oral anticoagulation in atrial fibrillation-associated stroke: prospective study of German stroke patients]. Reicke B; Masuhr F; Weih M Fortschr Neurol Psychiatr; 2008 Jul; 76(7):391-5. PubMed ID: 18604772 [TBL] [Abstract][Full Text] [Related]
15. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
16. Safety of percutaneous left atrial appendage closure with the Amplatzer cardiac plug in patients with atrial fibrillation and contraindications to anticoagulation. Wiebe J; Bertog S; Franke J; Wettstein O; Lehn K; Hofmann I; Vaskelyte L; Sievert H Catheter Cardiovasc Interv; 2014 Apr; 83(5):796-802. PubMed ID: 24327462 [TBL] [Abstract][Full Text] [Related]
17. Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms. Pisters R; de Vos CB; Nieuwlaat R; Crijns HJ Semin Thromb Hemost; 2009 Sep; 35(6):554-9. PubMed ID: 19787559 [TBL] [Abstract][Full Text] [Related]
18. New oral anticoagulants in elderly patients with atrial fibrillation. Deedwania PC Am J Med; 2013 Apr; 126(4):289-96. PubMed ID: 23369212 [TBL] [Abstract][Full Text] [Related]